FDA Approves Much-Debated Alzheimer’s Drug Panned by Experts

Automatic TRANSCRIPT

The food and drug administration approved the first new drug for Alzheimer's disease in nearly twenty years but there were doubts the drug is from Biogen magic can amount which is now could be marketed as and you held the FDA approved the drug saying it was based on results that seems reasonably likely to benefit Alzheimer's patients Dr Maria Correo is chief science officer with the Alzheimer's association this therapy slows the progression of the disease because it addresses the underlying biology one of the hallmarks of Alzheimer's which is amyloid plaques therapy usually manages symptoms of Alzheimer's like insomnia or anxiety FDA advisor Dr Caleb Alexander said no to the drug's approval he said the agency has regulatory standards based on evidence but in this case he thinks the product get a pass at Donahue Washington

Coming up next